Waters Corporation $WAT Shares Purchased by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd lifted its stake in Waters Corporation (NYSE:WAT) by 22.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 32,328 shares of the medical instruments supplier’s stock after acquiring an additional 6,000 shares during the period. Swiss Life Asset Management Ltd’s holdings in Waters were worth $12,124,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund increased its stake in Waters by 7.2% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 12,073 shares of the medical instruments supplier’s stock valued at $4,528,000 after purchasing an additional 807 shares in the last quarter. Axxcess Wealth Management LLC purchased a new position in shares of Waters in the second quarter worth $209,000. Mcdonald Partners LLC acquired a new stake in shares of Waters during the second quarter worth $81,000. Creative Financial Designs Inc. ADV lifted its stake in shares of Waters by 11.9% during the second quarter. Creative Financial Designs Inc. ADV now owns 722 shares of the medical instruments supplier’s stock worth $271,000 after buying an additional 77 shares during the period. Finally, Marks Group Wealth Management Inc grew its holdings in shares of Waters by 9.8% during the second quarter. Marks Group Wealth Management Inc now owns 4,920 shares of the medical instruments supplier’s stock valued at $1,845,000 after buying an additional 439 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Sanford C. Bernstein initiated coverage on Waters in a research report on Friday, June 26th. They issued an “outperform” rating and a $435.00 target price on the stock. Royal Bank Of Canada boosted their price target on Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Weiss Ratings lowered Waters from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday. Stifel Nicolaus set a $420.00 price objective on Waters in a research note on Wednesday, August 5th. Finally, Guggenheim reaffirmed a “buy” rating and set a $440.00 target price on shares of Waters in a report on Wednesday, July 8th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $420.35.

Waters Trading Down 0.3%

NYSE WAT opened at $414.90 on Friday. Waters Corporation has a 1 year low of $282.77 and a 1 year high of $420.26. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.77 and a quick ratio of 0.50. The company has a market capitalization of $40.76 billion, a PE ratio of 103.47, a P/E/G ratio of 2.42 and a beta of 1.19. The company has a fifty day moving average of $376.26 and a 200 day moving average of $345.85.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, beating analysts’ consensus estimates of $3.01 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The company’s revenue was up 113.3% on a year-over-year basis. During the same quarter last year, the business posted $2.95 EPS. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts forecast that Waters Corporation will post 14.57 earnings per share for the current year.

Insider Transactions at Waters

In other Waters news, Director Christopher A. Kuebler sold 3,626 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.31% of the company’s stock.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.